Delivery Order SPE2DB22D1017-SPE2DB24FG3KM

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $39K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,748.20 firm fixed-price delivery order is for the supply of 4,563,865,533 units of the prescription medication escitalopram 20 mg tablet. The contract has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,990.81 firm fixed-price contract is for the delivery of 1,000 tablets of the medication escitalopram 20 mg. The delivery order was issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $4,727.49 firm fixed-price contract is for the delivery of 4,563,678,932 tablets of the antidepressant medication escitalopram 20 mg. The contract has a period of performance through February 16, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,452.16, is for the delivery of 4,565,392 units of 20 mg Escitalopram tablets. The contract has an ultimate completion date of August 9, 2024 and was awarded on August 8, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,105.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,083,058 tablets of the medication Escitalopram 20 mg, a generic antidepressant drug. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 1, 2025. It is not designated as a set-aside contract,...
This federal contract award is for the delivery of 4,558,338,870 tablets of the prescription drug escitalopram 20 mg to the Defense Logistics Agency (DLA). The $27,595.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 6, 2022 with a completion date of September 7, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,034 units of the drug Escitalopram 10 mg tablets. The contract has a ceiling value of $6,074.93 and a completion date of February 24, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,250 tablets of the medication Escitalopram 10 mg. The contract has a ceiling value of $2,998.77 and a period of performance through May 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,587,337 tablets of the antidepressant medication escitalopram 10 mg. The $2,062.32 contract has a completion date of January 13, 2023 and is not designated as a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a $1,388.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 tablets of the prescription drug escitalopram 20 mg. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3KM
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $39,133.86 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 1,000 tablets of the antidepressant medication escitalopram 20 mg. The contract has an ultimate completion date of August 19, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. The contract was awarded on a full and open competition basis without any set-aside designations.

Generated 11/15/24, 9:11 AM